首页> 外文期刊>International journal of infectious diseases : >Pneumococcal conjugate vaccine (non-typeable Haemophilus influenzae (NTHi) Protein D, diphtheria or tetanus toxoid conjugates) in prevention of acute otitis media in children: A cohort study
【24h】

Pneumococcal conjugate vaccine (non-typeable Haemophilus influenzae (NTHi) Protein D, diphtheria or tetanus toxoid conjugates) in prevention of acute otitis media in children: A cohort study

机译:肺炎球菌结合疫苗(不可分型的流感嗜血杆菌(NTHi)D,白喉或破伤风类毒素结合物)预防儿童急性中耳炎的一项队列研究

获取原文
           

摘要

Background: Acute otitis media (AOM) is a common diagnosis among children. The most common causative bacteria in AOM are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. In March 2009, a pneumococcal vaccine containing ten serotype-specific polysaccharides conjugated to Haemophilus influenzae protein D, tetanus toxoid, and diphtheria toxoid as the carrier proteins was developed and licensed.
机译:背景:急性中耳炎(AOM)是儿童中的常见诊断。 AOM中最常见的致病菌是肺炎链球菌,流感嗜血杆菌和卡他莫拉菌。 2009年3月,开发并许可了一种肺炎球菌疫苗,该疫苗包含与流感嗜血杆菌D蛋白,破伤风类毒素和白喉类毒素缀合的十种血清型特异性多糖作为载体蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号